Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes

JAMA

2023-10-03

(Press-News.org) About The Study: In people with inadequately controlled type 2 diabetes treated with basal insulin in this randomized clinical trial with 1,428 participants, weekly tirzepatide compared with prandial insulin as an additional treatment with insulin glargine demonstrated reductions in HbA1c and body weight with less hypoglycemia.

Authors: Julio Rosenstock, M.D., of Velocity Clinical Research at Medical City in Dallas, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2023.20294)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Media advisory: This study is being released to coincide with presentation at the European Association for the Study of Diabetes Annual Meeting 2023.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.20294?guestAccessKey=829f6242-2bbd-4685-b1cb-603307c596d0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100323

END

ELSE PRESS RELEASES FROM THIS DATE:

New biobanking partnership safeguards the genetic diversity of America’s endangered species

2023-10-03

San Francisco, CA - The nonprofit Revive & Restore announces a groundbreaking new initiative to biobank U.S. endangered species, in partnership with the U.S. Fish & Wildlife Service. This multi-institution collaboration is the first systematic biobanking pipeline for U.S. threatened and endangered species. The initiative will protect genetic diversity for current and future recovery efforts. "This is about creating a legacy of America’s natural history before it is lost and provides an important resource to enhance species recovery efforts now and in the future,” said Ryan Phelan, Executive Director of Revive & ...

Eating disorders increased during pandemic in female adolescents and adults

2023-10-03

Emergency department (ED) visits and hospital admissions for eating disorders increased during the COVID-19 pandemic in adolescents aged 10–17 years, as did ED visits among young adults and older adults, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221318. Using ICES data, researchers compared observed and expected rates of ED visits and hospitalizations for eating disorders before (Jan. 1, 2017, to Feb. 29, 2020) and during the pandemic (Mar. 1, 2020, to Aug. 31, 2022) in adolescents (10–17 years), young adults (18–26 years), adults (27–40 years) ...

Improved mangrove conservation could yield cash, carbon, coastal benefits

2023-10-03

A shift in the way we think about the benefits mangroves provide to coastal regions could yield significant economic and biodiversity gains and protect millions from flooding, research has revealed. The University of Queensland-led study shows current conservation efforts typically target biodiversity protection whilst minimising conflict with economic interests, while failing to consider the huge benefits provided by ecosystems. Alvise Dabalà, now at the University of the Azores and whose Masters project at UQ formed the basis of this study, said human activities, such as deforestation and coastal development have led to extensive ...

Brain biometrics help identify sports concussions

2023-10-03

Novel brain biometrics could help inform whether an athlete is ready to return to play following a concussion, according to new research from the University of South Australia. Conducted in partnership with the University of California San Francisco (UCFC), researchers found that changes in micromovements of the brain – termed ‘headpulses’ – could detect the lasting impacts of a concussion. Using a custom-designed headset* to evaluate headpulse biometrics among 101 amateur male and female Australian ...

Study uncovers reasons Americans did not get booster vaccines

2023-10-03

The paper, “Understanding low bivalent COVID-19 booster uptake among US adults,” was published in the journal Vaccine. “Our results indicate that we have a lot more work to do in terms of educating the public and health care providers about the importance of staying up to date on COVID-19 boosters,” said first author Elizabeth Jacobs, PhD, professor of epidemiology at the Zuckerman College of Public Health, who led the research with associate professor of epidemiology Kristen Pogreba-Brown, PhD, MPH. Nearly 40% of survey participants reported they did not get a booster shot because ...

Texas engineers land semiconductor grants through CHIPS Act-backed NSF program

2023-10-03

A pair of Cockrell School research teams are part of a massive semiconductor grant program from the National Science Foundation that includes funds from industry leaders and the federal CHIPS Act. The projects are part of the NSF Future of Semiconductors (FuSe) program through a public-private partnership between NSF and four major tech companies: Ericsson, IBM, Intel and Samsung. FuSe aims to enable rapid progress in new semiconductor technologies and manufacturing as well as workforce development. Altogether, the program will support 24 research and ...

Gut bacteria found in wild wolves may be key to improving domestic dogs’ health

2023-10-03

BEND, Ore. – Gut microbes found in wild wolves may be the key to alleviating a debilitating gastrointestinal condition common to domestic dogs, according to a study led by researchers at Oregon State University – Cascades. In a paper published in Applied Microbiology, the authors report a novel strain of Paenibacillus bacteria with characteristics of a probiotic – an organism that conveys a health benefit to the host. In this case, the benefit would be to head off canine inflammatory ...

Host genetics helps explain childhood cancer survivors’ mortality risk from second cancers

2023-10-03

(MEMPHIS, Tenn. – October 02, 2023) The population of childhood cancer survivors in the U.S. is increasing, with an overall childhood cancer survival rate greater than 85% five years after diagnosis. However, survivors can still be at increased risk of various health conditions, including second cancers. Using data from the Childhood Cancer Survivor Study (CCSS) and the St. Jude Lifetime Cohort Study (St. Jude Life), scientists at St. Jude Children’s Research Hospital have identified a genetic ...

How floods kill, long after the water has gone – global decade-long study

2023-10-03

With New York declared a state of emergency following flash flooding, there is increasing concern such events will become more common globally. Now a study led by Monash University scientists in Australia has found that people impacted by a flooding event are at significantly increased risk of dying – including heart and lung problems – in a crucial window between three and six weeks after the event, even after the flooding has dissipated. The study, published today in the BMJ, found that the risk of dying increased and persisted for up to 60 days (50 days for cardiovascular mortality) after a flooded day - increasing by for 2.1% for all-cause deaths, 2.6% for cardiovascular ...

USC joins LA-area stem cell institutes in forming a regenerative medicine consortium

2023-10-03

USC is partnering with seven of Los Angeles’ leading regenerative medicine institutes to form the Los Angeles and surrounding area regenerative medicine consortium (LA-RMC), with the goal of fulfilling the promise of the California Institute for Regenerative Medicine (CIRM): to develop laboratory discoveries into treatments for patients with unmet medical needs. CIRM, the voter-created agency that provides public funding for stem cell research in California, is dedicated to advancing regenerative medicine, which uses stem cells and related approaches to treat disease and disorders. Regenerative ...

Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: